RNA Based Vaccine Market Regulatory Framework and Manufacturing Standards
The regulatory landscape for RNA based vaccines has evolved dramatically since the emergency use authorizations granted during the COVID-19 pandemic, transitioning toward comprehensive frameworks that govern full licensure, post-market surveillance, and manufacturing quality standards. The U.S. Food and Drug Administration established the framework for RNA vaccine approval through the Biologics...
0 Comments 0 Shares 74 Views 0 Reviews